{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:44:05Z","timestamp":1778867045871,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaapos.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jaapos.2022.07.001","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T06:49:38Z","timestamp":1663051778000},"page":"245.e1-245.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Refractive outcomes following unilateral laser treatment for type 1 retinopathy of prematurity"],"prefix":"10.1016","volume":"26","author":[{"given":"Sadik Etka","family":"Bayramoglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nihat","family":"Sayin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilbade Yildiz","family":"Ekinci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaapos.2022.07.001_bib1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ophtha.2014.07.050","article-title":"Pathophysiology and mechanisms of severe retinopathy of prematurity","volume":"122","author":"Hartnett","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2022.07.001_bib2","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial","volume":"121","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaapos.2022.07.001_bib3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3928\/15428877-20070501-09","article-title":"Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity","volume":"38","author":"Travassos","year":"2007","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"10.1016\/j.jaapos.2022.07.001_bib4","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/IAE.0b013e318177f934","article-title":"Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II","volume":"28","author":"Mintz-Hittner","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.jaapos.2022.07.001_bib5","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaapos.2022.07.001_bib6","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1542\/peds.81.5.697","article-title":"Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results","volume":"81","year":"1988","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaapos.2022.07.001_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0161-6420(92)31968-2","article-title":"Development of myopia in infants with birth weights less than 1251 grams. The Cryotherapy for Retinopathy of Prematurity Cooperative Group","volume":"99","author":"Quinn","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2022.07.001_bib8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0161-6420(00)00527-3","article-title":"Does cryotherapy affect refractive error? Results from treated versus control eyes in the cryotherapy for retinopathy of prematurity trial","volume":"108","author":"Quinn","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2022.07.001_bib9","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.ophtha.2005.03.025","article-title":"Prevalence of myopia at 9 months in infants with high-risk prethreshold retinopathy of prematurity","volume":"112","author":"Davitt","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2022.07.001_bib10","first-page":"124","article-title":"Progression of myopia and high myopia in the Early Treatment for Retinopathy of Prematurity study: findings at 4 to 6 years of age","volume":"17","author":"Quinn","year":"2013","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.jaapos.2022.07.001_bib11","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.ophtha.2007.07.028","article-title":"Progression of myopia and high myopia in the early treatment for retinopathy of prematurity study: findings to 3 years of age","volume":"115","author":"Quinn","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2022.07.001_bib12","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jamaophthalmol.2014.2772","article-title":"Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial","volume":"132","author":"Geloneck","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jaapos.2022.07.001_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/IAE.0000000000001125","article-title":"Outcomes after laser versus combined laser and bevacizumab treatment for type 1 retinopathy of prematurity in zone I","volume":"37","author":"Yoon","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.jaapos.2022.07.001_bib14","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ophtha.2014.12.017","article-title":"Outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity: a 5-year retrospective analysis","volume":"122","author":"Hwang","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2022.07.001_bib15","first-page":"141","article-title":"Comparison of intravitreal ranibizumab and diode laser photocoagulation treatment for retinopathy of prematurity; effects on axial length and refractive status","volume":"9","author":"Sukgen","year":"2019","journal-title":"Sakarya T\u0131p Dergisi"},{"key":"10.1016\/j.jaapos.2022.07.001_bib16","first-page":"365","article-title":"Treatment of type I ROP with intravitreal bevacizumab or laser photocoagulation according to retinal zone","volume":"101","author":"Mueller","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaapos.2022.07.001_bib17","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3341\/kjo.2019.0011","article-title":"Refractive outcomes of 4-year-old children after intravitreal anti-vascular endothelial growth factor versus laser photocoagulation for retinopathy of prematurity","volume":"33","author":"Kang","year":"2019","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.jaapos.2022.07.001_bib18","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1080\/02713683.2016.1264607","article-title":"Comparison of intravitreal bevacizumab, intravitreal ranibizumab and laser photocoagulation for treatment of type 1 retinopathy of prematurity in Turkish preterm children","volume":"42","author":"Kabata\u015f","year":"2017","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jaapos.2022.07.001_bib19","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The International Classification of Retinopathy of Prematurity revisited","volume":"123","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaapos.2022.07.001_bib20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00006324-199706000-00019","article-title":"Power vectors: an application of Fourier analysis to the description and statistical analysis of refractive error","volume":"74","author":"Thibos","year":"1997","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.jaapos.2022.07.001_bib21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ophtha.2009.06.008","article-title":"Anisometropia in Hispanic and African American infants and young children: the Multi-Ethnic Pediatric Eye Disease Study","volume":"117","author":"Borchert","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2022.07.001_bib22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000521070","article-title":"The effect of intravitreal bevacizumab dose on retinal vascular progression in retinopathy of prematurity","volume":"245","author":"Bayramoglu","year":"2022","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.jaapos.2022.07.001_bib23","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1177\/11206721211064019","article-title":"Inter-eye comparison of retinal vascular growth rate and angiographic findings following unilateral bevacizumab treatment","volume":"32","author":"Bayramoglu","year":"2022","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jaapos.2022.07.001_bib24","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.ophtha.2021.05.031","article-title":"International classification of retinopathy of prematurity","volume":"128","author":"Chiang","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2022.07.001_bib25","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1007\/s10792-022-02321-6","article-title":"Factors associated with refractive outcome in children treated with bevacizumab for retinopathy of prematurity: the importance of retinal vascularization","volume":"42","author":"Bayramoglu","year":"2022","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jaapos.2022.07.001_bib26","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41433-019-0605-x","article-title":"Is the severity of refractive error dependent on the quantity and extent of retinal laser ablation for retinopathy of prematurity?","volume":"34","author":"Young-Zvandasara","year":"2020","journal-title":"Eye"},{"key":"10.1016\/j.jaapos.2022.07.001_bib27","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1038\/s41433-020-01321-z","article-title":"Risk factors for myopia at 1-year corrected age following laser photocoagulation for retinopathy of prematurity","volume":"35","author":"Mori","year":"2021","journal-title":"Eye"},{"key":"10.1016\/j.jaapos.2022.07.001_bib28","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/bjo.2005.083535","article-title":"Change of refractive state and eye size in children of birth weight less than 1701 g","volume":"90","author":"O'Connor","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaapos.2022.07.001_bib29","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s10792-021-02119-y","article-title":"Angiographic findings in cases with a history of severe retinopathy of prematurity treated with anti-VEGFs: follow-up to age 6 years","volume":"42","author":"Celiker","year":"2022","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jaapos.2022.07.001_bib30","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.ophtha.2016.06.055","article-title":"Chronic vascular arrest as a predictor of bevacizumab treatment failure in retinopathy of prematurity","volume":"123","author":"Toy","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2022.07.001_bib31","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/IAE.0000000000001581","article-title":"Prophylactic peripheral laser and fluorescein angiography after bevacizumab for retinopathy of prematurity","volume":"38","author":"Gonzalez","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.jaapos.2022.07.001_bib32","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3928\/23258160-20211031-02","article-title":"Management of type 2 retinopathy of prematurity or less in infants aged 45 weeks postmenstrual age or older","volume":"52","author":"Wood","year":"2021","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.jaapos.2022.07.001_bib33","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1136\/bjophthalmol-2017-311789","article-title":"Incidence, risk factors and severity of retinopathy of prematurity in Turkey (TR-ROP study): a prospective, multicentre study in 69 neonatal intensive care units","volume":"102","author":"Bas","year":"2018","journal-title":"Br J Ophthalmol"}],"container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853122004189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853122004189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:25:54Z","timestamp":1761078354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091853122004189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1091853122004189"],"URL":"https:\/\/doi.org\/10.1016\/j.jaapos.2022.07.001","relation":{},"ISSN":["1091-8531"],"issn-type":[{"value":"1091-8531","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Refractive outcomes following unilateral laser treatment for type 1 retinopathy of prematurity","name":"articletitle","label":"Article Title"},{"value":"Journal of American Association for Pediatric Ophthalmology and Strabismus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaapos.2022.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}